Massachusetts Institute of Technology

The General Hospital Corporation

Daniel Blankschtein

Robert Samuel Langer

Samir Suresh Mitragotri

Carlo Giovanni Traverso

Carl Magnus Schoellhammer

Baris Erinc Polat

Daniel Griffith Anderson

Michael V Pishko

Joseph Kost

Robert S Langer, Jr

Avraham D Schroeder

Avraham Schroeder

Mark E Johnson

William Brugge

Chia-Li Liu

Baris Polat

Apparatus, kits, and methods for administering a substance are presented. A device for administering a substance includes an elongated body having a proximal end and a distal end, the elongated body defining an internal chamber extending between the proximal end and the distal end to direct the substance to the distal end, the distal end to connect with a tip, the tip to be at least partially inserted into an orifice of a body lumen of a subject, the tip having a shape configured to reduce leakage of the substance from the orifice upon the at least partial insertion. The tip includes an opening to pass the substance from the internal chamber into the body lumen; and a transducer to emit an ultrasound wave from the tip into the body lumen, thereby administering the substance to tissue in the body lumen.

Systems, apparatus, and methods for administering a substance

The present disclosure provides devices and uses thereof. A devices disclosed herein comprises a plurality of microneedles adapted to protrude from the device. In some embodiments, a device is dimensioned and constructed to carry a payload, so that the payload can be delivered to an internal tissue of a subject or through a wall of a vessel after interaction with microneedles. In some embodiments, devices can be used for oral or intravenous administration. In some embodiments, devices can be used for implantation such as vaginal, rectal, urethral or bladder suppository or pessary.

Microneedle devices and uses thereof

Applications of low-frequency (20 KHz) ultrasound enhances transdermal transport of high-molecular weight proteins. This method includes a simultaneous application of ultrasound and protein on the skin surface in order to deliver therapeutic doses of proteins across the skin. Examples demonstrate in vitro and in vivo administration of insulin (molecular weight 6,000 D), and in vitro administration of gamma interferon (molecular weight 17,000 D), and erythropoeitin (molecular weight 48,000 D).

Transdermal protein delivery or measurement using low-frequency

Transdermal protein delivery using low-frequency sonophoresis

Transdermal transport of molecules during sonophoresis (delivery or extraction) can be further enhanced by providing chemical enhancers which increase the solubility of the compound to be transported and/or lipid bilayer solubility, and/or additional driving forces for transport, such as mechanical or osmotic pressure, magnetic fields, electroporation or iontophoresis. In a preferred embodiment the ultrasound is low frequency ultrasound which induces cavitation of the lipid layers of the stratum corneum (SC). This method provides higher drug transdermal fluxes, allows rapid control of transdermal fluxes, and allows drug delivery or analyte extraction at lower ultrasound intensities and other forces or concentrations than that required if each means of enhancing transport is used individually.

Chemical and physical enhancers and ultrasound for transdermal drug

Transdermal delivery of encapsulated drugs

The present invention provides a method, device and diagnostic kit for separating and/or concentrating an analyte from a mixture containing one or more contaminants according to size using a two-phase aqueous micellar system. The methods and devices are applicable to a wide range of analytes including environmental pollutants and biological materials. Conditions for optimizing size separation of analyte and contaminant are provided and include selection of a single surfactant type or surfactant mixture, surfactant concentration and composition, temperature, pH, salt type and concentration, and the addition of polymers. The separation or concentration efficiencies can be further enhanced by repeatedly generating the two-phase aqueous systems in a multi-stage operation. This invention can be used for removing viruses from proteins following fermentation processes, as well as for concentrating viruses for vaccine manufacturing or gene therapy.

Separation and/or concentration of an analyte from a mixture using a

Growing community of inventors

Brookline, MA, United States of America

Daniel Blankschtein